These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 29111150
1. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y. J Control Release; 2017 Dec 28; 268():407-415. PubMed ID: 29111150 [Abstract] [Full Text] [Related]
3. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY, Jung E, Park JH, Park JW, Shim CK, Kim DD, Yoon IS, Cho HJ. J Colloid Interface Sci; 2016 Oct 15; 480():102-108. PubMed ID: 27421112 [Abstract] [Full Text] [Related]
5. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS. Int J Nanomedicine; 2013 Oct 15; 8():2975-83. PubMed ID: 23976850 [Abstract] [Full Text] [Related]
7. Effect of PLGA NP size on efficiency to target traumatic brain injury. Cruz LJ, Stammes MA, Que I, van Beek ER, Knol-Blankevoort VT, Snoeks TJA, Chan A, Kaijzel EL, Löwik CWGM. J Control Release; 2016 Feb 10; 223():31-41. PubMed ID: 26708021 [Abstract] [Full Text] [Related]
8. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Navarro SM, Darensbourg C, Cross L, Stout R, Coulon D, Astete CE, Morgan T, Sabliov CM. Ther Deliv; 2014 Nov 10; 5(11):1191-201. PubMed ID: 25491670 [Abstract] [Full Text] [Related]
10. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Czuba E, Diop M, Mura C, Schaschkow A, Langlois A, Bietiger W, Neidl R, Virciglio A, Auberval N, Julien-David D, Maillard E, Frere Y, Marchioni E, Pinget M, Sigrist S. Int J Pharm; 2018 May 05; 542(1-2):47-55. PubMed ID: 29501738 [Abstract] [Full Text] [Related]
11. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S, Sahoo SK. Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969 [Abstract] [Full Text] [Related]
12. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy. Voon SH, Tiew SX, Kue CS, Lee HB, Kiew LV, Misran M, Kamkaew A, Burgess K, Chung LY. J Biomed Nanotechnol; 2016 Jul 30; 12(7):1431-52. PubMed ID: 29336539 [Abstract] [Full Text] [Related]
13. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N, Alam MA, Ahmad R, Naqvi AA, Ahmad FJ. Artif Cells Nanomed Biotechnol; 2018 Mar 30; 46(2):432-446. PubMed ID: 28503995 [Abstract] [Full Text] [Related]
14. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882 [Abstract] [Full Text] [Related]
15. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Cai H, Liang Z, Huang W, Wen L, Chen G. Int J Pharm; 2017 Oct 30; 532(1):55-65. PubMed ID: 28870763 [Abstract] [Full Text] [Related]
16. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line. Lin D, Li G, Qin L, Wen Z, Wang J, Sun X. J Biomed Nanotechnol; 2013 Dec 30; 9(12):2017-23. PubMed ID: 24266257 [Abstract] [Full Text] [Related]